| Medical Mutual | Vyxeos® (daunorubicin and cytarabine – liposome) (Intravenous) | 2025-04-07 |
| Medical Mutual | Xenpozyme® (olipudase alfa) (Intravenous) | 2025-04-07 |
| Medical Mutual | Ziihera® (zanidatamab-hrii) (Intravenous) | 2025-04-07 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Opioid Dependence Therapy | 2025-04-07 |
| Medicare FCSO | Billing and Coding: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor (57884) | 2025-04-04 |
| Medicare Novitas | Billing and Coding: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor (57839) | 2025-04-04 |
| Medicare CGS | Ostomy Supplies - Policy Article (52487) | 2025-04-03 |
| Medicare Noridian | Ostomy Supplies - Policy Article (52487) | 2025-04-03 |
| BCBS Texas Medical Policies | Adipose-Derived Stem Cells in Autologous Fat Grafting to the | 2025-04-01 |
| BCBS Texas Medical Policies | Biofeedback as a Treatment of Fecal Incontinence or | 2025-04-01 |